The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2023

Filed:

Jan. 18, 2019
Applicant:

Taro Pharmaceutical Industries Ltd., Haifa Bay, IL;

Inventors:

Avi Avramoff, Haifa Bay, IL;

Helena Shifrin, Haifa Bay, IL;

Ron Schlinger, Haifa Bay, IL;

Tzviel Sheskin, Haifa Bay, IL;

Zeev Elkoshi, Haifa Bay, IL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7068 (2006.01); A61P 17/12 (2006.01); A61K 9/00 (2006.01); A61K 31/122 (2006.01); A61K 31/196 (2006.01); A61K 31/437 (2006.01); A61K 31/4412 (2006.01); A61K 31/513 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7068 (2013.01); A61K 9/0014 (2013.01); A61K 31/122 (2013.01); A61K 31/196 (2013.01); A61K 31/437 (2013.01); A61K 31/4412 (2013.01); A61K 31/513 (2013.01); A61P 17/12 (2018.01);
Abstract

The present invention relates to a novel and unexpected method of using topical Capecitabine composition to obtain therapeutically effective amounts of fluorouracil (FU) within the skin of a subject afflicted with hyperproliferative or inflammatory skin condition. The method comprising topically administering a pharmaceutical composition comprising Capecitabine or a hydrate or solvate thereof to the affected area of the skin of the subject, to form therapeutically effective amounts of FU within the skin.


Find Patent Forward Citations

Loading…